SCHEMBL942067

SCHEMBL942067

COc1cc(C)cc(N2CCN(c3ccc(N)cc3)CC2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.46
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 7/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
GFER P55789 5/20 0.45
GAA P10253 4/20 0.45
ADRA2C P18825 1/20 0.45
KMT2A Q03164 1/20 0.45
PTK2B Q14289 1/20 0.45
ESR2 Q92731 1/20 0.45
RECQL P46063 1/20 0.43
RAD52 P43351 1/20 0.42
HSD17B10 Q99714 2/20 0.42
TSHR P16473 1/20 0.42
CASP1 P29466 1/20 0.42
AHR P35869 1/20 0.42
CASP7 P55210 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL943023 0.82 MAPT (0.55) MAPTKDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1020078 0.81 SIRT6 (0.51) MAPTALDH1A1SMN1; SMN2KMT2ALMNA
SCHEMBL22495410 0.80 MAPT (0.47) MAPTKDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL942722 0.79 MAPT (0.51) MAPTKDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL17696413 0.79 SMN1; SMN2 (0.46) KDM4EALDH1A1SMN1; SMN2L3MBTL1TDP1
SCHEMBL943619 0.78 MAPT (0.50) MAPTKDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1126498 0.74 MAPT (0.50) MAPTKDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1645628 0.74 MAPT (0.58) MAPTKDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL15938175 0.73 HRH4 (0.54) HRH4
SCHEMBL15938328 0.72 HRH4 (0.49) MAPTKDM4EALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524705-B2 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl)-acetamide derivatives and related compounds as antifungal agents F2G LIMITED BRITISH BODY CORPORATE (GB) 2013-09-03 US disclosed
US-20110009390-A1 2-OXO-2- (2-PHENYL-5,6,7,8-TETRAHYDRO-INDOLIZIN-3-YL) -ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ANTIFUNGAL AGENTS F2G LIMITED (GB) 2011-01-13 US disclosed
EP-2173749-B1 2-OXO-2- (2-PHENYL-5,6,7,8-TETRAHYDRO-INDOLIZIN-3-YL) -ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ANTIFUNGAL AGENTS F2G LTD (GB) 2011-01-12 EP disclosed
EP-2173749-A1 2-OXO-2- (2-PHENYL-5,6,7,8-TETRAHYDRO-INDOLIZIN-3-YL) -ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ANTIFUNGAL AGENTS F2G Limited (GB) 2010-04-14 EP disclosed
WO-2008145963-A1 2-OXO-2- (2-PHENYL-5,6,7,8-TETRAHYDRO-INDOLIZIN-3-YL) -ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ANTIFUNGAL AGENTS F2G LIMITED (GB) 2008-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009390-A1 2-OXO-2- (2-PHENYL-5,6,7,8-TETRAHYDRO-INDOLIZIN-3-YL) -ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ANTIFUNGAL AGENTS NAT1, FOXM1, CYP51A1 MAPT 2462/4885KDM4E 2650/4885ALDH1A1 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.